Company profile for Nabriva Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases. Our dedicated team includes people with extensive science and industry experience and a shared passion for addressing the increasingly urgent problem of bacterial resistance worldwide. Nabriva is a commercial-stage biopharmaceutical company with locations in the United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), an...
Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases. Our dedicated team includes people with extensive science and industry experience and a shared passion for addressing the increasingly urgent problem of bacterial resistance worldwide. Nabriva is a commercial-stage biopharmaceutical company with locations in the United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
25-28 North Wall Quay, IFSC, Dublin 1
Telephone
Telephone
+353 1 649 2000
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/meitheal-acquires-contepo-from-nabriva-therapeutics-to-expand-specialty-biopharmaceuticals-portfolio-15908

INDIANPHARMAPOST
24 Jul 2024

https://www.businesswire.com/news/home/20240718082874/en

BUSINESSWIRE
18 Jul 2024
Century, Elevation to cut assets, staff; Nabriva winds down
Century, Elevation to cut assets, staff; Nabriva winds down

06 Jan 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/century-elevation-are-latest-follow-layoff-pipeline-cull-route-nabriva-winds-down

James Waldron FIERCE BIOTECH
06 Jan 2023

https://www.globenewswire.com//news-release/2023/01/06/2584338/37424/en/Nabriva-Therapeutics-Provides-Corporate-Update.html

GLOBENEWSWIRE
06 Jan 2023

https://www.globenewswire.com//news-release/2022/11/28/2563012/37424/en/Nabriva-Therapeutics-Announces-Positive-Topline-Results-from-Phase-1-Trial-of-XENLETA-lefamulin-in-Adult-Patients-with-Cystic-Fibrosis.html

GLOBENEWSWIRE
28 Nov 2022
Nabriva halts R&D, lays off 40% of staff in commercial refocus
Nabriva halts R&D, lays off 40% of staff in commercial refocus

11 Nov 2022

// James Waldron FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/nabriva-halts-rd-lays-40-staff-commercial-focused-pivot-survival

James Waldron FIERCEBIOTECH
11 Nov 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty